» Articles » PMID: 27059970

Long-term Efficacy of Modified Retrievable Stents for Treatment of Achalasia Cardia

Overview
Journal Surg Endosc
Publisher Springer
Date 2016 Apr 10
PMID 27059970
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the efficacy, safety and optimal duration of placement of modified retrievable metal stents for treatment of achalasia cardia.

Methods: Patients were randomly divided into groups A (N = 26, modified stents for 3 days), B (N = 26, modified stents for 2 days), C (N = 24, balloon dilation), and D (N = 25, regular stents for 2 days). Clinical symptom scores were recorded at baseline, 6 months, and during long-term follow-up.

Results: Seventy-seven patients with achalasia underwent stent placement (100 % success rate of implantation and extraction, no perforation). No stent migration or drop-off occurred in groups A and B. In group D, stent drop-off and migration was observed in 2 and 1 patients, respectively. Two patients in group C sustained esophageal perforation. Patients in the modified stent (A and B), balloon dilated (C) and regular stents (D) groups experienced significant improvement in dysphagia at 6 months, with recurrence in 1.92, 8.33 and 28 %, respectively. The clinical symptom score in the modified stent groups was significantly lower than that in the balloon dilated group (P = 0.01). During long-term follow-up, the symptom scores in modified stent groups were significantly lower than that in the balloon dilated (P < 0.01) and regular stent (P < 0.01) groups.

Conclusion: Modified retrievable metal stents required an optimal placement duration of 2 days were safe with no incidence of migration or drop-off and had a lower recurrence of symptoms.

Citing Articles

Evaluating the Non-conventional Achalasia Treatment Modalities.

Tustumi F Front Med (Lausanne). 2022; 9:941464.

PMID: 35814742 PMC: 9263126. DOI: 10.3389/fmed.2022.941464.


Achalasia: treatment, current status and future advances.

Swanstrom L Korean J Intern Med. 2019; 34(6):1173-1180.

PMID: 30866609 PMC: 6823561. DOI: 10.3904/kjim.2018.439.

References
1.
Werner Y, Costamagna G, Swanstrom L, von Renteln D, Familiari P, Sharata A . Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut. 2015; 65(6):899-906. DOI: 10.1136/gutjnl-2014-308649. View

2.
von Renteln D, Fuchs K, Fockens P, Bauerfeind P, Vassiliou M, Werner Y . Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology. 2013; 145(2):309-11.e1-3. DOI: 10.1053/j.gastro.2013.04.057. View

3.
Zhao J, Li Y, Cheng Y, Li M, Chen N, Chen W . Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience. Eur Radiol. 2009; 19(8):1973-80. PMC: 2705705. DOI: 10.1007/s00330-009-1373-y. View

4.
Verlaan T, Rohof W, Bredenoord A, Eberl S, Rosch T, Fockens P . Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia. Gastrointest Endosc. 2013; 78(1):39-44. DOI: 10.1016/j.gie.2013.01.006. View

5.
Campos G, Vittinghoff E, Rabl C, Takata M, Gadenstatter M, Lin F . Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2008; 249(1):45-57. DOI: 10.1097/SLA.0b013e31818e43ab. View